Literature DB >> 29685194

Pseudoesterase activity of albumin: A probable determinant of cholesterol biosynthesis.

Deepak Kumar1, Sakshi Behal2, Rajasri Bhattacharyya1, Dibyajyoti Banerjee3.   

Abstract

The association between hypoalbuminemia and coronary artery disease is known from some time. However, the reason as to how such phenomenon is correlated remains unknown. We have observed from published scientific literature that HSA has the potential to control cholesterol biosynthesis due to its pseudoesterase activity. In-silico observations have supported our view since acetyl coA, the precursor molecule of cholesterol biosynthesis is shown to bind with Tyr 411 of HSA. Incidentally, Tyr411 is a critical moiety for pseudoesterase activity of albumin. With this frame of reference in mind we hypothesize that pseudoesterase activity of HSA is an important determinant of lipid metabolism including cholesterol biosynthesis. Therefore, albumin has the potential to influence the atherosclerotic state important for pathogenesis of coronary artery diseases.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery diseases; Human serum albumin; Hypercholesterolemia; Hypertriglyceridemia; Hypoalbuminemia; Pseudoesterase

Mesh:

Substances:

Year:  2018        PMID: 29685194     DOI: 10.1016/j.mehy.2018.03.018

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

Review 1.  The Effect of Recombinant Human Erythropoietin on Bacterial Growth: A Dual-Edged Sword.

Authors:  Ankur Mittal; Vandana Singh; Sheemona Chowdhary; Amal Moideen; Deepak Kumar; Kunal Maniar; Rajasri Bhattacharyya; Dibyajyoti Banerjee
Journal:  Kidney Dis (Basel)       Date:  2018-11-13

2.  Cholesterol affects the relationship between albumin and major adverse cardiac events in patients with coronary artery disease: a secondary analysis.

Authors:  Yu-Feng Yao; Zhen-Yu Chen; Tian-Yi Luo; Xiao-Yan Dou; Hai-Bo Chen
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.